When I was writing my list, I forgot to mention the annual shareholder meeting before end of this year.
What about NWBO's need for revenue to pay salaries, keep the lights on, pay Advent, resume work on DCVax-Direct, etc. Basically, the company's intense need for operating cash?
If they wish to remain independent (which aligns well with my understanding of management's philosophy) doesn't it make sense for them to take the path of least resistance, i.e. 1 approval in 1 friendly jurisdiction (the UK), which opens the door to commercial sales, and begin to actually book some sales revenue, as opposed to relying on loans and endless dilutions of shareholder equity?
Market Data 
Markets 
AI
